Determinants of achieving serum urate goal with treat‐to‐target urate‐lowering therapy in gout: comment on the article by Helget et al

Documents similaires

• Balancing weight reduction benefits and risks: implications for serum urate management. Comment on the article by Fukui et al
  par: Pei Liu, et autres
  Publié: (2025)
• Target trial emulation and cardiovascular safety inference in gout: comment on the article by Yokose et al.
  par: Jian Huang
  Publié: (2026)
• Methodological considerations for “Proinflammatory dietary pattern and the risk of female gout”: comment on the article by Rai et al
  par: Fusen Chen, et autres
  Publié: (2025)
• Short‐term risk of cardiovascular events in people newly diagnosed with gout: comment on the article by Cipolletta et al
  par: Teng‐Fei Li, et autres
  Publié: (2025)
• Short‐term risk of cardiovascular events in people newly diagnosed with gout: comment on the article by Cipolletta et al
  par: Zichang Liu, et autres
  Publié: (2025)